Phenytoin 4-hydroxylation by rabbit liver P450IIC3 and identification of orthologs in human liver microsomes

https://doi.org/10.1016/0006-291X(90)90889-UGet rights and content

Abstract

The ability of rabbit liver microsomes to 4-hydroxylate phenytoin to 5-(4-hydroxyphenyl)-5-phenylhydantoin was studied. No significant difference was observed between the capacity of control and rifampicin, phenobarbital, acetone, 2,3,7,8-tetrachlorodibenzo-p-dioxin and phenytoin induced rabbit liver microsomes to 4-hydroxylate phenytoin. In reconstitution experiments using six purified rabbit cytochromes P450 isozymes, only P450IIC3 was capable of 4-hydroxylating phenytoin whereas P450IA1, P450IA2, P450IIB4, P450IIIA6, and P450IVB1 were inactive. Further, anti-P450IIC3 IgG completely inhibited phenytoin 4-hydroxylase activity in rabbit liver microsomes. The above data suggest a major role for the constitutive isozyme P450IIC3 in phenytoin 4-hydroxylase activity in rabbit liver. In human liver microsomes P450IIC3 IgG inhibited phenytoin 4-hydroxylase activity by 66%, suggesting that an ortholog to rabbit P450IIC3 is in part responsible for this activity in man.

References (22)

  • F.P. Guengerich et al.

    J. Biol. Chem

    (1986)
  • H.H. Dieter et al.

    J. Biol. Chem

    (1982)
  • J. Ozols et al.

    J. Biol. Chem

    (1985)
  • M.M. McKinney et al.

    J. Immunolog. Methods

    (1987)
  • T. Shimada et al.

    J. Biol. Chem

    (1986)
  • R.G. Dickinson et al.

    Ther. Drug. Monit

    (1985)
  • M.J. Eadie et al.

    Clin. Exp. Pharmacol. Physiol

    (1976)
  • E. Perucca

    Clin. Pharmacokin

    (1982)
  • H. Kutt et al.

    Neurology

    (1964)
  • M.R. Vasko et al.

    Clin. Pharmacol. Ther

    (1980)
  • P. Vermeij et al.

    Clin. Pharmacol. Ther

    (1988)
  • Cited by (33)

    • Phenytoin – An anti-seizure drug: Overview of its chemistry, pharmacology and toxicology

      2020, Food and Chemical Toxicology
      Citation Excerpt :

      Therefore, CYP3A4-metabolised drugs may generally be required during concurrent treatment with phenytoin (Hole et al., 2018). Research has also been conducted to study phenytoin metabolism in animal subjects (Chow et al., 1980; Billings, 1983; Doecke et al., 1990). It should be noted that rates of 4′-HPPH formation in rat liver microsomes were 10 times higher than in humans (Munns et al., 1997).

    View all citing articles on Scopus
    View full text